Fidelity D & D Bancorp Inc Abbott Laboratories Transaction History

Fidelity D & D Bancorp Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$109.52 - $120.96 $5,256 - $5,806	-48 Reduced 2.52%	1,860 $211 Million
Q4 2023 Jan 12, 2024	SELL	$90.19 - $110.4 $30,123 - $36,873	-334 Reduced 14.9%	1,908 $210 Million
Q3 2023 Nov 30, 2023	BUY	$95.53 - $114.62 $214,178 - $256,978	2,242 New	2,242 $217 Million
Q1 2023 Apr 16, 2024	SELL	$96.86 - $114.01 $4,649 - $5,472	-48 Reduced 2.52%	1,860 $211 Million

3,137

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Fidelity D & D Bancorp Inc, based on Form 13F filings with the SEC.

Stay updated on Fidelity D & D Bancorp Inc with notifications on news.